Valuation Ono Pharmaceutical Co., Ltd.

Stocks

Market Closed - Japan Exchange 01:30:00 2026-11-13 EST			5-day change	1st Jan Change
2,472.00 ^JPY	-0.58%		+5.08%	+13.79%

10-29	Ono Pharmaceutical Posts Higher Fiscal H1 Core Profit; Revenue Down	MT
10-28	Ono Pharmaceutical Co., Ltd. Announces Dividend for the End of Second Quarter of Fiscal Year Ending March 31, 2027, Payable on December 1, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	1,512,876	1,349,755	1,152,917	752,707	1,179,703	1,162,104	-	-
Change	-	-10.78%	-14.58%	-34.71%	56.73%	-1.49%	-	-
Enterprise Value (EV) ¹	1,443,704	1,253,600	986,776	678,661	1,063,532	960,165	910,886	861,974
Change	-	-13.17%	-21.28%	-31.22%	56.71%	-9.72%	-5.13%	-5.37%
P/E	18.9x	12x	9.21x	15x	16.9x	15.5x	18.1x	16.2x
PBR	2.28x	1.82x	1.45x	0.96x	1.39x	1.31x	1.26x	1.22x
PEG	-	0.3x	0.6x	-0.2x	0.4x	2.08x	-1.3x	1.4x
Capitalization / Revenue	4.19x	3.02x	2.29x	1.55x	2.29x	2.51x	2.59x	2.52x
EV / Revenue	4x	2.8x	1.96x	1.39x	2.06x	2.08x	2.03x	1.87x
EV / EBITDA	11.9x	7.86x	5.54x	7.83x	8.18x	6.94x	7.64x	6.72x
EV / EBIT	14x	8.83x	6.17x	11.4x	11.5x	9.68x	10.8x	9.12x
EV / FCF	21.3x	8.64x	15.8x	-12.5x	11x	8.43x	10.4x	10.2x
FCF Yield	4.7%	11.6%	6.34%	-8%	9.12%	11.9%	9.6%	9.83%
Dividend per Share ²	56	70	80	80	80	80	80	80
Rate of return	1.83%	2.53%	3.26%	4.99%	3.19%	3.24%	3.24%	3.24%
EPS ²	162.2	230.8	266.6	106.6	148.5	159.6	136.6	152.8
Distribution rate	34.5%	30.3%	30%	75.1%	53.9%	50.1%	58.6%	52.4%
Net sales ¹	361,361	447,187	502,672	486,871	515,785	462,564	448,822	461,092
EBITDA ¹	120,916	159,414	178,075	86,641	129,988	138,300	119,301	128,295
EBIT ¹	103,195	141,963	159,935	59,747	92,236	99,231	84,194	94,473
Net income ¹	80,519	112,723	127,977	50,047	69,767	75,378	64,178	71,820
Net Debt ¹	-69,172	-96,155	-166,141	-74,046	-116,171	-201,939	-251,218	-300,130
Reference price ²	3,066.00	2,764.00	2,454.50	1,602.50	2,510.50	2,472.00	2,472.00	2,472.00
Nbr of stocks (in thousands)	493,436	488,334	469,716	469,708	469,908	470,107	-	-
Announcement Date	5/11/22	5/10/23	5/9/24	5/8/25	5/8/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ONO PHARMACEUTICAL CO., LTD.	15.58x	2.09x	6.99x	3.22%	7.31B
ELI LILLY AND COMPANY	41.92x	14.14x	29.98x	0.48%	1,271B
JOHNSON & JOHNSON	41.5x	6.96x	19.58x	1.88%	683B
ABBVIE INC.	37.54x	8.61x	17.78x	2.34%	520B
ROCHE HOLDING AG	21.85x	5.3x	13.27x	2.47%	389B
MERCK & CO., INC.	104.3x	5.95x	25.36x	2.31%	362B
NOVARTIS AG	24.13x	5.85x	14.24x	2.72%	304B
ASTRAZENECA PLC	24.18x	4.84x	13.59x	1.81%	286B
AMGEN INC.	24.11x	7.4x	13.59x	2.16%	253B
GILEAD SCIENCES, INC.	-39.46x	7.31x	46.04x	1.97%	208B
Average	29.57x	6.85x	20.04x	2.14%	428B
Weighted average by Cap.	37.28x	8.87x	22.50x	1.69%